ATE495750T1 - Sulfatide zur behandlung von autoimmunkrankheiten - Google Patents
Sulfatide zur behandlung von autoimmunkrankheitenInfo
- Publication number
- ATE495750T1 ATE495750T1 AT06816075T AT06816075T ATE495750T1 AT E495750 T1 ATE495750 T1 AT E495750T1 AT 06816075 T AT06816075 T AT 06816075T AT 06816075 T AT06816075 T AT 06816075T AT E495750 T1 ATE495750 T1 AT E495750T1
- Authority
- AT
- Austria
- Prior art keywords
- sulfatides
- treatment
- autoimmune
- immune related
- autoimmune diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72218405P | 2005-09-29 | 2005-09-29 | |
PCT/US2006/038539 WO2007038785A1 (en) | 2005-09-29 | 2006-09-28 | Sulfatides for treatment of autoimmune disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE495750T1 true ATE495750T1 (de) | 2011-02-15 |
Family
ID=37532920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06816075T ATE495750T1 (de) | 2005-09-29 | 2006-09-28 | Sulfatide zur behandlung von autoimmunkrankheiten |
Country Status (8)
Country | Link |
---|---|
US (1) | US8044029B2 (de) |
EP (1) | EP1940418B1 (de) |
JP (1) | JP2009510124A (de) |
AT (1) | ATE495750T1 (de) |
CA (1) | CA2623946A1 (de) |
DE (1) | DE602006019759D1 (de) |
ES (1) | ES2360235T3 (de) |
WO (1) | WO2007038785A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5564672B2 (ja) * | 2006-06-30 | 2014-07-30 | ザ スクリプス リサーチ インスティテュート | アジュバント及びその使用方法 |
KR102055395B1 (ko) | 2011-06-24 | 2019-12-12 | 쥐알아이 바이오,아이엔씨. | 염증 질환의 예방 및 치료 |
EP3229811B1 (de) | 2014-12-09 | 2021-02-24 | GRI Bio, Inc. | Vorbeugung und behandlung von inflammatorischen krankeiten |
WO2021236389A2 (en) * | 2020-05-16 | 2021-11-25 | Bond Jason R | Treatment of known and unknown viral infection with lipid agents |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5674690A (en) * | 1992-10-08 | 1997-10-07 | New York University | Methods of diagnosis, monitoring and staging of various conditions using IgG antibodies against hydroxy-fatty acid containing sulfatide |
CA2142153A1 (en) * | 1994-03-04 | 1995-09-05 | Jacques Banville | Sulfated .beta.-glycolipid derivatives as cell adhesion inhibitors |
CA2194492A1 (en) * | 1994-07-27 | 1996-02-08 | Sabine Flitsch | Regioselective sulfation |
US5486536A (en) * | 1994-08-15 | 1996-01-23 | The Regents Of The University Of Michigan | Sulfatides as anti-inflammatory compounds |
JPH08109134A (ja) | 1994-10-11 | 1996-04-30 | Sanwa Kagaku Kenkyusho Co Ltd | 細胞変成抑制並びに臓器毒性軽減剤 |
SE9601817D0 (sv) * | 1996-05-13 | 1996-05-13 | Karsten Buschard | Novel glycolipid complexex and their uses |
JP5090928B2 (ja) * | 2004-12-28 | 2012-12-05 | ザ ロックフェラー ユニバーシティ | Nkt細胞に対する抗原としての糖脂質及びその類似体 |
-
2006
- 2006-09-28 CA CA002623946A patent/CA2623946A1/en not_active Abandoned
- 2006-09-28 US US11/529,793 patent/US8044029B2/en not_active Expired - Fee Related
- 2006-09-28 EP EP06816075A patent/EP1940418B1/de not_active Not-in-force
- 2006-09-28 DE DE602006019759T patent/DE602006019759D1/de active Active
- 2006-09-28 ES ES06816075T patent/ES2360235T3/es active Active
- 2006-09-28 WO PCT/US2006/038539 patent/WO2007038785A1/en active Application Filing
- 2006-09-28 JP JP2008533762A patent/JP2009510124A/ja active Pending
- 2006-09-28 AT AT06816075T patent/ATE495750T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US8044029B2 (en) | 2011-10-25 |
ES2360235T3 (es) | 2011-06-02 |
EP1940418A1 (de) | 2008-07-09 |
JP2009510124A (ja) | 2009-03-12 |
CA2623946A1 (en) | 2007-04-05 |
WO2007038785A1 (en) | 2007-04-05 |
US20070087979A1 (en) | 2007-04-19 |
EP1940418B1 (de) | 2011-01-19 |
DE602006019759D1 (de) | 2011-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007136518A3 (en) | Treatment of autoimmune disorders | |
MX2014002459A (es) | Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y metodos de uso de los mismos. | |
EP2331095A4 (de) | Bestimmte kynurenin-3-monooxygenase-inhibitoren, pharmazeutische zusammensetzungen und anwendungsverfahren dafür | |
CY1111478T1 (el) | Ενδειξη δοσολογιας προγεστερονης στην αντιμετωπιση τραυματικης εγκεφαλικης βλαβης | |
EA201200686A1 (ru) | Новые терапевтические подходы для лечения болезни альцгеймера | |
EA200700427A1 (ru) | Предупреждение и лечение синуклеинопатических и амилоидогенных заболеваний | |
CY1111359T1 (el) | Μεμαντινη για την θεραπεια ηπιας εως μετριας ασθενειας alzheimer | |
EA201000914A1 (ru) | Новые терапевтические подходы в лечении смт и связанных с ней расстройств | |
EA201391581A1 (ru) | Способы лечения болезни альцгеймера, болезни хантингтона, аутизма и других расстройств | |
PH12017502049A1 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
MX2014001088A (es) | Ciertos inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas, y metodos de uso de las mismas. | |
NO20074999L (no) | Metode og preparat for behandling av perifere vaskulaere sykdommer | |
EA200802204A1 (ru) | Применение ингибиторов dpp iv | |
EA201590655A1 (ru) | Комбинация лахинимода и придопидина для лечения нейродегенеративных нарушений | |
SG158089A1 (en) | Antiangiogenesis therapy of autoimmune disease in patients who have failed prior therapy | |
ATE552837T1 (de) | Verwendung von hochdosierten oxazaphosphorin- arzneimitteln zur behandlung von immunstörungen | |
ATE470151T1 (de) | Diagnose, behandlung und prävention von gefässerkrankungen mittels il-1alpha- autoantikörpern | |
EA200800007A1 (ru) | Фармацевтические композиции на основе нейроактивного стероида и их применение | |
WO2007053661A3 (en) | Uses of anti-cd40 antibodies | |
EA201270144A1 (ru) | Комбинированная терапия при лечении диабета | |
EA200971053A1 (ru) | Способы лечения кожных язв | |
EA200600921A1 (ru) | Способы и композиции с применением талидомида для лечения и менеджмента рака и других заболеваний | |
EA200970127A1 (ru) | Модулятор рецепторов глюкокортикостероидов и способы его применения | |
ATE495750T1 (de) | Sulfatide zur behandlung von autoimmunkrankheiten | |
ATE487480T1 (de) | Perhexilin zur behandlung von chronischer herzinsuffizienz |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |